Funding for this research was provided by:
Brain and Behavior Research Foundation (Young Investigator Award)
Received: 29 May 2020
Revised: 11 June 2020
Accepted: 18 June 2020
First Online: 8 July 2020
Conflict of interest
: The content is solely the responsibility of the authors and does not necessarily represent the official views of Massachusetts General Hospital, Harvard University, and its affiliated academic healthcare centers, or the NIH. Intellectual property (IP) has been filed around [<sup>11</sup>C]Martinostat by J.M.H. and C.W.; A portion of this IP has been licensed. J.M.H. is a co-founder and equity holder of Eikonizo Therapeutics, Inc. and has received honoraria for speaking or advisory service at non-profit academic institutions. In the past year, J.M.H. has consulted for Psy Therapeutics, Inc., Amathus Therapeutics Inc., Evelo Biosciences Inc., Rodin Therapeutics Inc., and the Alzheimer’s Drug Discovery Foundation. T.M.G. is a current employee of Eikonizo Therapeutics, Inc. The remaining authors declare no competing interests.